Skip to content
healthcare.dev

Magnesium Oxide

NDC 24689-132, Magnesium Oxide, tablet, from APNAR PHARMA LP.

Product NDC
24689-132
Status
Listed
Labeler
APNAR PHARMA LP
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M001
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/24689-132 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MAGNESIUM OXIDE400 mg/1

Pharmacologic classes

Calculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
24689-132-0124689013201120 TABLET in 1 BOTTLE (24689-132-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 24689013201

    GET /v1/drugs/nadac/24689013201

Use it

Look up 24689-132 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/24689-132 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 24689-132. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.